Showing results (81-90 of 523) with videos related to
Sort By:
Pageof 53
Current Opinion in Pharmacology|August 14, 2022
Mechanisms of cardio-renal protection of sodium-glucose cotransporter-2 inhibitorsMartina Chiriacò, Domenico Tricò, Anna SoliniJournal of the Renin-Angiotensin-Aldosterone System : JRAAS|June 14, 2003
ACE inhibition or angiotensin receptor blockade: which should we use in diabetic patients?Luis M Ruilope, Julian Segura, Ernesto L SchiffrinExpert Review of Cardiovascular Therapy|July 1, 2011
New clinical concepts after the ONTARGET trialLuis M Ruilope, Julian Segura, Jose L ZamoranoJournal of Diabetes Investigation|May 17, 2016
Syphilis iridocyclitis in a patient with type 1 diabetesMario Comassi, Andrea Natali, Anna SoliniJournal of the American Society of Nephrology : JASN|December 3, 2014
The dark side of extracellular ATP in kidney diseasesAnna Solini, Vera Usuelli, Paolo FiorinaCurrent Opinion in Clinical Nutrition and Metabolic Care|October 16, 2020
Protein and amino acids in nonalcoholic fatty liver diseaseDomenico Tricò, Edoardo Biancalana, Anna SoliniJournal of the American Society of Nephrology : JASN|June 7, 2005
Calcium channel blockers and renal protection: insights from the latest clinical trialsJulián Segura, José A García-Donaire, Luis M RuilopeCurrent Opinion in Nephrology and Hypertension|August 19, 2007
Are differences in calcium antagonists relevant across all stages of nephropathy or only proteinuric nephropathy?Julián Segura, José A García-Donaire, Luis M RuilopeJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|June 10, 2009
Target organ damage: how to detect it and how to treat it?Bernard Waeber, Alejandro de la Sierra, Luis M RuilopeDrugs in R&D|May 21, 2014
Clinical implications of the 2013 ESH/ESC hypertension guidelines: targets, choice of therapy, and blood pressure monitoringSverre E Kjeldsen, Tonje A Aksnes, Luis M RuilopePageof 53